Aptose Biosciences Inc. (APTO)
Aptose Biosciences Statistics
Share Statistics
Aptose Biosciences has 2.14M shares outstanding. The number of shares has increased by 9.13% in one year.
| Shares Outstanding | 2.14M |
| Shares Change (YoY) | 9.13% |
| Shares Change (QoQ) | -5.28% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 2.14M |
| Failed to Deliver (FTD) Shares | 43.11K |
| FTD / Avg. Volume | 10.17% |
Short Selling Information
The latest short interest is 1.31M, so 2.18% of the outstanding shares have been sold short.
| Short Interest | 1.31M |
| Short % of Shares Out | 2.18% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 0.07 |
Valuation Ratios
The PE ratio is -10.05 and the forward PE ratio is -0.09. Aptose Biosciences's PEG ratio is -0.74.
| PE Ratio | -10.05 |
| Forward PE | -0.09 |
| PS Ratio | 0 |
| Forward PS | 1 |
| PB Ratio | -177.43 |
| P/FCF Ratio | -11.54 |
| PEG Ratio | -0.74 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aptose Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of -0.35.
| Current Ratio | 0.78 |
| Quick Ratio | 0.78 |
| Debt / Equity | -0.35 |
| Total Debt / Capitalization | -53.82 |
| Cash Flow / Debt | -43.93 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 17.65% and return on capital (ROIC) is 2776.03%.
| Return on Equity (ROE) | 17.65% |
| Return on Assets (ROA) | -3.94% |
| Return on Capital (ROIC) | 2776.03% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,463,057.14 |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -94.33% in the last 52 weeks. The beta is 0.91, so Aptose Biosciences's price volatility has been higher than the market average.
| Beta | 0.91 |
| 52-Week Price Change | -94.33% |
| 50-Day Moving Average | 5.87 |
| 200-Day Moving Average | 13.73 |
| Relative Strength Index (RSI) | 35.16 |
| Average Volume (20 Days) | 423.68K |
Income Statement
| Revenue | n/a |
| Gross Profit | -474.55K |
| Operating Income | -52.36M |
| Net Income | -51.21M |
| EBITDA | -52.27M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -7.58 |
Balance Sheet
The company has 9.25M in cash and 1.01M in debt, giving a net cash position of 8.24M.
| Cash & Cash Equivalents | 9.25M |
| Total Debt | 1.01M |
| Net Cash | 8.24M |
| Retained Earnings | -515.54M |
| Total Assets | 10.93M |
| Working Capital | 477K |
Cash Flow
In the last 12 months, operating cash flow was -44.59M and capital expenditures -29K, giving a free cash flow of -44.62M.
| Operating Cash Flow | -44.59M |
| Capital Expenditures | -29K |
| Free Cash Flow | -44.62M |
| FCF Per Share | -6.61 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APTO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -238.36% |
| FCF Yield | -654.63% |
Analyst Forecast
The average price target for APTO is $150, which is 4617% higher than the current price. The consensus rating is "Buy".
| Price Target | $150 |
| Price Target Difference | 4617% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 26, 2025 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -10.69 |
| Piotroski F-Score | 1 |